Sales of Receivables

3 Months Ended

May 01, 2026

Note 9—Sales of Receivables:

The Company has a Master Accounts Receivable Purchase Agreement ("MARPA Facility") for the sale of up to a maximum amount of $300 million of certain designated eligible receivables with the U.S. government.

MARPA Facility activity consisted of the following:


	Three Months Ended
	May 1, 2026		May 2, 2025
	(in millions)
Beginning balance	$	164	$	164
Sale of receivables	814		1,243
Cash collections	(814)		(1,107)
Outstanding balance sold(1)	164		300
Cash collected, not remitted(2)	(48)		(109)
Remaining sold receivables(3)	$	116	$	191

(1) For the three months ended May 1, 2026, there was no net impact to cash flows from operating activities from sold receivables. For the three months ended May 2, 2025, the Company recorded a net increase of $136 million to cash flows from operating activities from sold receivables.

(2) The Cash collected, not remitted balance is included in "Accounts payable" on the condensed consolidated balance sheets.

(3) The Remaining sold receivables balance is included in "Receivables, net" on the condensed consolidated balance sheets.